Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host diseaseJohn E. Levine, James L.M. Ferrara, Sophie Paczesny et al.|Blood|2007Cited by 190
Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized studyMitchell E. Horwitz, Guillermo Sanz, Joseph P. McGuirk et al.|Blood|2021Cited by 110
Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective SeriesAttaphol Pawarode, Daniel R. Couriel, Shin Mineishi et al.|Transplantation and Cellular Therapy|2015Cited by 12
Improved Clinical Outcomes with Omidubicel Versus Standard Myeloablative Umbilical Cord Blood Transplantation: Results of a Phase III Randomized, Multicenter StudyMitchell E. Horwitz, Einat Galamidi, Corey Cutler et al.|Transplantation and Cellular Therapy|2021Cited by 3